glp 1 weight gain GLP-1 Drugs: Fighting Diabetes and Gain💊 - General GLP-1 receptor agonists 'superior' for

Lilly shares are down less than 1%

M.VangoneA

See our full guide on compounded GLP-1 medications for the current legal and clinical landscape

Several GLP-1 agonists have FDA approval for other indications that may overlap with BED patient populations: Semaglutide (Wegovy) and liraglutide (Saxenda) are approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity Semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro) are approved for type 2 diabetes management Tirzepatide (Zepbound) is approved for chronic weight management When clinicians prescribe GLP-1 agonists for BED, this constitutes off-label use a legal and common practice in medicine when evidence suggests potential benefit and approved treatments are inadequate

It is therefore important to question the traditional step-by-step approach to treating obesity and to tailor treatments to individual patients'needs